Sigma-Aldrich
Life Science

Antibody Explorer
Automation
Cancer Research
Cell Culture
Cell Signaling and Neuroscience
Custom Synthesis
Drug Discovery
Epigenetics
Functional Genomics and RNAi
Metabolomics
Molecular Biology
Nutrition Research
Obesity Research
Plant Biotechnology
Proteomics and Protein Expr.
Stable Isotopes
Your Favorite Gene - Search
Life Science Quarterly
PathFinder
PathFinder - Help


PathFinder Cell Signaling Pathway

www.sigmaaldrich.com/pathfinder
Sigma-Aldrich
Launch PathFinder
to see a detailed, interactive version of this map

NOTE: PathFinder requires the Flash plug-in for proper viewing. It will launch in a separate pop-up window, please turn off any pop-up blockers for this web site.

Akt Signaling
Copyright ©2006 ProteinLounge.com

 Akt Signaling

The protein kinase B, PKB, family of proteins, also called Akt or RAC, are serine/threonine protein kinases involved in the regulation of cell survival; cell cycle progression; protein synthesis; glucose/glycogen metabolism; and a growing list of specialized cell function. Akt/PKB exists as three isoforms: AKT1 (PKB); AKT2 (PKBbeta); and AKT3 (PKBgamma). Akt/PKB is activated by phosphorylation. The principle Akt/PKB kinase is 3-phosphoinositide dependent protein kinase-1 (PDK1 (PKPK1)). Akt/PKB is dephosphorylated by protein phosphatase 2A (PP2A). Akt/PKB is maintained in an active phosphorylated state by the ligand occupation of various cytokine and growth factor receptors. Ligand-withdrawal or down-regulation of Akt/PKB activators leads to apoptosis.

Akt/PKB mediates cell survival signaling by phosphorylating several factors involved in apoptosis machinery including: caspase-9, BCL2-antagonist of cell death (BAD), forkhead in rhabdomyosarcoma-like 1 (FKHRL1); IκB kinase, IKKalpha (an NFkappaBp65 activator). Akt/PKB upregulates protein synthesis by turning off constitutively active glycogen synthase kinase-3, GSK3; and turning on mTOR (TORC1). Akt/PKB promotes cell-cycle progression by phosphorylating cyclin-dependent kinase (CDK) inhibitors; p27(Kip1) and p21(CIP1). Akt/PKB attenuates the action of the second messenger cAMP by activating the cAMP phosphodiesterases-3B (PDE-3B). Akt/PKB promotes the uptake of glucose by promoting the translocation of the GLUT-4 glucose transporter to the cell membrane.


References:

    Downward, J. (1988) Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10, 262-267.

    Jimenez, C. et. al. (2002) The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras. J. Biol. Chem. 277(44):41556-41562.

    Kitamura, T. et. al. (1999) Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol. Cell Biol. 19, 6286-6296.

    Ruggero, D. and Sonenberg, N. (2005) The Akt of translational control. Oncogene. 24, 7426-34.

    Testa, J. R. and Tsichlis, P. N. (2005) AKT signaling in normal and malignant cells. Oncogene. 7391-7393.

    Zhou, X. M. et. al. (2000) Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J. Biol. Chem. 275, 25046-25051.

Back to top

Content for this page is provided by Dennis R. Conrad, Ph.D., a Life Science industry consultant with over 25 years of experience in the formulation and optimization of cell culture media. Dr. Conrad's email address is biomediaexpert@earthlink.net